Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance
In the last few decades, targeting cancer by the use of dietary phytochemicals has gained
enormous attention. The plausible reason and believe or mind set behind this fact is …
enormous attention. The plausible reason and believe or mind set behind this fact is …
A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases
Iron plays a vital role in several cellular functions due to its unique physiochemical
properties. Iron concentration increases in the brain with age due to multiple factors …
properties. Iron concentration increases in the brain with age due to multiple factors …
Silybin phytosome attenuates cerebral ischemia‐reperfusion injury in rats by suppressing oxidative stress and reducing inflammatory response: In vivo and in silico …
PK Pasala, RK Uppara, M Rudrapal… - … of Biochemical and …, 2022 - Wiley Online Library
The present study was aimed to develop silybin phytosome (SIBP) and evaluate its
effectiveness against cerebral ischemia‐reperfusion (CIR) injury in rats. Initially, SIBP was …
effectiveness against cerebral ischemia‐reperfusion (CIR) injury in rats. Initially, SIBP was …
[HTML][HTML] Involvement of estrogen receptor-α in the activation of Nrf2-antioxidative signaling pathways by silibinin in pancreatic β-cells
C Chu, X Gao, X Li, X Zhang, R Ma, Y Jia… - Biomolecules & …, 2020 - ncbi.nlm.nih.gov
Silibinin exhibits antidiabetic potential by preserving the mass and function of pancreatic β-
cells through up-regulation of estrogen receptor-α (ERα) expression. However, the …
cells through up-regulation of estrogen receptor-α (ERα) expression. However, the …
[HTML][HTML] Role of heat shock protein 70 in silibinin-induced apoptosis in bladder cancer
Y Wei, Y Zhuang, Y Zhang, L Luo, B Yu, J Zeng - Journal of Cancer, 2024 - ncbi.nlm.nih.gov
Abstract Hsp70 (heat shock protein 70) plays critical roles in cancer cell proliferation and
apoptosis. Recently, accumulating evidences have demonstrated the cancer promoting …
apoptosis. Recently, accumulating evidences have demonstrated the cancer promoting …
[HTML][HTML] The potential of herbal drugs to treat heart failure: The roles of Sirt1/AMPK
T Zhang, L Xu, X Guo, H Tao, Y Liu, X Liu… - Journal of …, 2023 - Elsevier
Heart failure (HF) is a highly morbid syndrome that seriously affects the physical and mental
health of patients and generates an enormous socio-economic burden. In addition to cardiac …
health of patients and generates an enormous socio-economic burden. In addition to cardiac …
Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy
K Liu, S Zhou, J Liu, Y Wang, F Zhu… - Drug design, development …, 2019 - Taylor & Francis
Aim Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Silibinin is
a flavonoid compound which has medicinal value. Previous studies revealed that silibinin …
a flavonoid compound which has medicinal value. Previous studies revealed that silibinin …
Effect of silibinin on the expression of MMP2, MMP3, MMP9 and TIMP2 in kidney and lung after hepatic ischemia/reperfusion injury in an experimental rat model
V Kollaras, G Valsami, M Lambropoulou… - Acta Cirúrgica …, 2021 - SciELO Brasil
Purpose: The protective effect of silibinin on kidney and lung parenchyma during hepatic
ischemia/reperfusion injury (IRI) is explored. Methods: Sixty-three Wistar rats were …
ischemia/reperfusion injury (IRI) is explored. Methods: Sixty-three Wistar rats were …
Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model
CY Yang, CH Tsao, CC Hsieh, CK Lin, CS Lin, YH Li… - PLoS …, 2020 - journals.plos.org
Dysregulation of histone demethylase Jumonji-C domain-containing protein 5 (JMJD5) has
been identified as a great effect on tumorigenesis. Silibinin is a commonly used anti …
been identified as a great effect on tumorigenesis. Silibinin is a commonly used anti …
The natural estrogen receptor beta agonist silibinin as a promising therapeutic tool in diffuse large B-cell lymphoma
E Ortona, SL Locatelli, MT Pagano… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: About 40% of patients with diffuse large cell lymphoma (DLBCL) still have
a poor prognosis. Additionally, DLBCL patients treated with doxorubicin are at risk of cardiac …
a poor prognosis. Additionally, DLBCL patients treated with doxorubicin are at risk of cardiac …